Holy Haid

Beijing Holy-Haid Pharmaceutical is a Chinese pharmaceutical company specializing in the development and manufacturing of finished dosage forms, particularly injectables and oral medications. Based in Beijing, the company focuses on therapeutic areas including cardiovascular and cerebrovascular diseases, anti-infectives, and digestive system disorders. Since its acquisition by Haisco Pharmaceutical Group in 2012, Holy-Haid has served as a critical manufacturing hub, leveraging its GMP-certified facilities to produce key products like Alprostadil and Cefuroxime. The company plays a vital role in Haisco's strategy to provide high-quality generic and specialized treatments within the Chinese healthcare market. Its operations are centered in the Beijing Economic-Technological Development Area, where it maintains robust production and quality control standards.